The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 2.00 — grey zone — between safe and distressedWatch
- Earnings-manipulation signal · Beneish M 0.16 — flag raised, worth a closer lookWatch
- Earnings quality 87/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2024, as Hims & Hers Health, Inc. reports it. History and quarterly detail are in the app.
- Sales Channel Directly To Consumer$1.4B
- Sales Channel Through Intermediary$38.6M
Leadership changes
From Hims & Hers Health, Inc.'s own filings, the day they're filed.
- Melissa Baird · Chief Operating Officer · departureeff. 2025-04-21
- Christopher Payne · appointmenteff. 2024-11-15
- K. Additionally · directors · appointmenteff. 2024-11-15
Latest filings
- 8-K · Company announcement2026-06-15
- 8-K · Company announcement2026-06-02
- 8-K · Company announcement2026-05-21
- 8-K · Company announcement2026-05-19
- 8-K · Company announcement2026-05-11
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Hims & Hers Health, Inc., every answer cited🔒
- The Intelligence Brief — added when Hims & Hers Health, Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.